Pharmaceutical, Healthcare & Life-Sciences


Pharmaceutical, Healthcare & Life-Sciences


The Indian pharmaceutical industry is a success story now providing employment for millions. A highly regulated sector, the Indian Pharma Industry is growing at about 8 to 9 percent annually and is expected to grow to US$ 12 billion by 2010. The presence of low-cost production facilities and a large science base is helping drive this trend. India is emerging as an attractive destination for clinical trials. Today, the market value of clinical research outsourced to India is estimated at US$ 100 million. The booming healthcare market has opened a window of opportunities in the medical device field, as well. The Indian biotech sector is expected to create about one million jobs by 2010.

To partner our clients as they enter the regulated global markets and consolidate their operations in the domestic pharma marketplace Ross Warner has in place a team of 10 consultants and researchers. The team at Ross Warner has executed over 125 mandates in the last year in diverse areas such as sales and marketing, international sales, manufacturing, operation, research and development, regulatory and quality control for Fortune 500 clients and large Indian corporates in this industry space.

Life Sciences & Healthcare

The healthcare industry in India has come a long way from the days when those who could afford it had to travel abroad to get highly specialized services, while others had to do without it. Today, patients from neighbouring countries in Asia are coming to India to receive specialized medical treatment. Not only the country is meeting international standards, but also at prices that compare very favorably with developed countries.

The demand for healthcare services in India has grown from $ 4.8 billion in 1991 to $ 22.8 billion in 2001-02, indicating a compounded annual growth rate of 16 per cent. The healthcare industry accounted for 5.2 per cent of India's GDP in 2002, and this figure could reach $ 47 billion or 6.2-7.5 per cent of GDP by 2012. The supply of healthcare services has grown steadily as the private sector becomes more involved in owning and running hospitals.